Tuesday, September 28, 2004
Prescription Drugs

New Medicare Rules May Increase Risk from Unregulated Compounded Drug Copies

Rep. Waxman asks HHS to revise the proposed Medicare rule that would allow the use of pharmacist-made copies of brand-name prescription drugs to ensure that seniors are not exposed to the serious health risks posed by these non-FDA approved drugs.